Comparison

KAG-308 European Partner

€8,560.00
Excl. VAT
Item no. HY-128686-50mg
Manufacturer MedChem Express
CASRN 1215192-68-9
Amount 50 mg
Category
Type Inhibitors
Specific against other
Purity 99.88
Formula C24H30F2N4O3
Citations [1]Watanabe Y, et al. KAG-308, a newly-identified EP4-selective agonist shows efficacy for treating ulcerative colitis and can bring about lower risk of colorectal carcinogenesis by oral administration. Eur J Pharmacol. 2015 May 5;754:179-89.
Smiles O[C@H](C1)[C@H](/C=C/[C@@H](O)[C@@H](C2=CC=CC(C)=C2)C)[C@](C/3(F)F)([H])[C@@]1([H])OC3=C/CCCC4=NN=NN4
ECLASS 10.1 32160490
ECLASS 11.0 32160490
UNSPSC 12000000
Alias 1215192-68-9
Similar products 1215192-68-9
Available
Product Description
KAG-308 is a potent selective and orally active agonist of EP4 receptor (a prostaglandin E2 receptor subtype), suppresses colitis and promotes histological mucosal healing, potently inhibits TNF-α production. KAG-308 shows a Ki and an EC50 of 2.57 nM and 17 nM for human EP4 receptor, respectively, more selective over EP1, EP2, EP3 and IP receptor[1].
StorageTemperature
-20°C (Powder, stored under nitrogen)
Shipping
Blue Ice
Manufacturers Applications
COVID-19-immunoregulation
Molecular Weight
460.52
Clinical Information
No Development Reported
Solubility
|DMSO : 80 mg/mL (ultrasonic)
Isoform
EP
Pathway
GPCR/G Protein
Manufacturers Product type
Reference compound

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 50 mg
Available: In stock
Listprice: €8,560.00
Price: €8,560.00
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close